Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 58 (3) , 136-141
- https://doi.org/10.1136/ard.58.3.136
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Enhanced Th2-like responses in IL-1 type 1 receptor-deficient miceEuropean Journal of Immunology, 1998
- Role of interleukin 10 in specific immunotherapy.Journal of Clinical Investigation, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- Interleukin‐10 inhibition of the progression of established collagen‐induced arthritisArthritis & Rheumatism, 1996
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.The Journal of Experimental Medicine, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990